Î¥Ï€Î¿Ï ÏÎ³Î¹ÎºÎ® απόφαση

ΕΦΗΜΕΡΙΣ ΤΗΣ ΚΥΒΕΡΝΗΣΕΩΣ (ΤΕΥΧΟΣ ΔΕΥΤΕΡΟ) 19153
L -
ATC / . DDD MON
( )
L02AE02 LEUPRORELIN ACETATE
L02AE02 L 1927602 01 DARONDA DEPOT PS.INJ.SUS 3,75MG/VIAL BTx1VIAL+1 AMP ABBVIE 0.00013 G 27.985 2.6554 74.31 71.20
L02AE02 L 1927604 01 DARONDA DEPOT PS.INJ.SUS 11,25MG/VIAL BTx1 ABBVIE 0.00013 G 83.955 2.4724 207.57 207.57
L02AE02 L 1997001 02 ELITYRAN PS.INJ.SUS 3,75MG/VIALPF BTx 1 PF.SYR + VIANEX A.E. 0.00013 G 27.985 2.9444 82.40 71.20
L02AE02 L 1997002 03 ELITYRAN PS.INJ.SUS 11,25MG/VIALP BT x 1 PF.SYR + VIANEX A.E. 0.00013 G 83.955 2.6247 220.36 213.61
L02AE02 L 2704401 01 LEUPROL PS.INJ.SUS 3,75MG/VIAL : 0.00013 G 27.985 2.2251 62.27 62.27
L02AE02 L 2704402 01 LEUPROL PS.INJ.SUS 11,25MG/VIAL : 0.00013 G 83.955 2.5477 213.89 213.61
L02AE04 TRIPTORELINE
L02AE04 T 1960801 02 ARVEKAP PS.INJ.SUS 3,75MG/VIAL BTxVIAL+1AMP S IPSEN 0.00013 G 27.985 3.5976 100.68 71.20
L02AE04 T 1960803 02 ARVEKAP PS.INJ.SUS 11,25MG/VIAL BTx1VIAL+1AMP IPSEN 0.00013 G 83.955 2.9385 246.70 213.61
L02AE04 T 2524201 01 GONAPEPTYL DEPOT PD.S.IN.SR 3,75MG/PF BTx1PFS+1PFS FERRING . 0.00013 G 27.985 4.2712 119.53 71.20
( )
L02AE01 BUSERELIN ACETATE
L02AE01 B 1913902 02 SUPREFACT INJ.SOL 1MG/ML BT x 2 VIALS x 7 SANOFI-AVENTIS AE 0.0015 G 9.333 2.1579 20.14 20.14
L02AE02 LEUPRORELIN ACETATE
L02AE02 L 1927601 01 DARONDA INJ.SOL 14MG/2,8ML VIA BTx1 VIALx2,8 M ABBVIE 0.001 G 14.000 6.5414 91.58 83.18
L02AE04 TRIPTORELINE
L02AE04 T 1960802 01 ARVEKAP LY.PD.INJ 0,1MG/VIAL BT x 7 VIALS x 0 IPSEN 1 TE 7.000 4.6857 32.80 32.80
L02AE04 T 2524202 01 GONAPEPTYL DAILY INJ.SOL 0,1MG/1ML PF.S BTx7 (PF.SYR. x FERRING . 1 TE 7.000 6.2029 43.42 41.59
( )
L02AE01 BUSERELIN ACETATE
L02AE01 B 1913901 01 SUPREFACT M.D.NAS.SP 100MCG/DOSE BT x 4 FL x100 D SANOFI-AVENTIS AE 0.0012 G 33.333 2.2728 75.76 75.76
L02B -A
L02BA -A-
( )
L02BA01 TAMOXIFEN CITRATE
L02BA01 T 2412602 01 ADIFEN TAB 20MG/TAB BTx30(BLIST 3x1 MEDICAMERC A.E. 0.02 G 30.000 0.1720 5.16 5.16